Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease
Journal of Digestive Diseases · 2023
DOI: 10.1111/1751-2980.13223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Virginia Gregorio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Whipple Disease, Immune Reconstitution Inflammatory Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Whipple's disease (WD) is a rare and potentially fatal infectious disease caused by Tropheryma whipplei . It is characterized by a long prodromal phase that mimics a rheumatological disease, often leading to immunosuppressant treatment. Immune reconstitution inflammatory syndrome (IRIS) is currently the most important complication of WD, requiring prompt recognition and treatment as it can be fatal. However, epidemiological data on IRIS are scarce. We aimed to identify the clinical and laboratory predictors of IRIS at WD diagnosis and to evaluate whether the prevalence of IRIS has changed over time.
Methods
Forty‐five patients with WD (mean age 52 ± 11 years; 10 females) were followed up between January 2000 and December 2021. Clinical and laboratory data at WD diagnosis were retrospectively collected and compared among patients who developed IRIS and those who did not.
Results
Erythrocyte sedimentation rate (ESR; 33.4 ± 11.8 mm/h vs 67.1 ± 26.3 mm/h, P < 0.01), platelet (PLT; 234 × 10 9 /L vs 363 × 10 9 /L, P < 0.01), and body mass index (22.0 ± 2.0 kg/m 2 vs 19.8 ± 3.0 kg/m 2 , P = 0.04) differed significantly between patients who subsequently developed IRIS and those who did not. ROC analysis identified ESR ≤46 mm/h (AUROC 0.88, 95% CI 0.72–1.00) and PLT ≤ 327 × 10 9 /L (AUROC 0.85, 95% CI 0.70–1.00) as optimal cut‐off values to discriminate WD patients at a high risk of developing IRIS. Prevalence of IRIS remained stable (22.2%) over time.
Conclusions
Low ESR and PLT count at diagnosis help identify WD patients at high risk of developing IRIS. Instead, a greater inflammatory response suggests a lower risk of IRIS. Prevalence of IRIS did not change over two decades.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
- Department of Microbiology & Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Istituti Clinici Scientifici Maugeri, IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.
ORCID-Profile: Stiliano Maimaris, Federico Biagi, Annalisa Schiepatti
Zitieren
APA
Gregorio, V., Albrizio, A., Maimaris, S., Scalvini, D., Scarcella, C., Cambieri, P., Biagi, F., & Schiepatti, A. (2023). Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13223
Vancouver
Gregorio V, Albrizio A, Maimaris S, Scalvini D, Scarcella C, Cambieri P, et al. Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13223
BibTeX
@article{Gregorio2023,
author = {Gregorio, Virginia and Albrizio, Alessandra and Maimaris, Stiliano and Scalvini, Davide and Scarcella, Chiara and Cambieri, Patrizia and Biagi, Federico and Schiepatti, Annalisa},
title = {Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease},
journal = {Journal of Digestive Diseases},
year = {2023},
doi = {10.1111/1751-2980.13223}
}
EUVIMED